M. Evans

990 total citations
13 papers, 353 citations indexed

About

M. Evans is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, M. Evans has authored 13 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in M. Evans's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (3 papers) and Synthesis and bioactivity of alkaloids (2 papers). M. Evans is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (3 papers) and Synthesis and bioactivity of alkaloids (2 papers). M. Evans collaborates with scholars based in United Kingdom and United States. M. Evans's co-authors include Heinz G. Boettger, J M Gilbert, J.T. Cummins, T. George Bidder, A E Kark, C Lombard, K. Hellmann, Paul G. Cassell, D. J. Rowlands and C Wastell and has published in prestigious journals such as Journal of Chromatography A, Life Sciences and British journal of surgery.

In The Last Decade

M. Evans

12 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Evans United Kingdom 11 109 89 80 67 57 13 353
Melvin D. Brannan United States 10 132 1.2× 55 0.6× 54 0.7× 67 1.0× 24 0.4× 18 531
Prashant Naik India 10 75 0.7× 69 0.8× 75 0.9× 28 0.4× 110 1.9× 24 306
Bjarne Due Larsen Denmark 10 264 2.4× 38 0.4× 69 0.9× 133 2.0× 22 0.4× 19 482
R. Hulhoven Belgium 12 114 1.0× 93 1.0× 33 0.4× 154 2.3× 24 0.4× 38 472
Hideaki Mizumoto Japan 10 101 0.9× 28 0.3× 74 0.9× 21 0.3× 44 0.8× 28 379
Lena L. Neri United States 8 102 0.9× 24 0.3× 38 0.5× 89 1.3× 16 0.3× 9 403
Takahiro Kawai Japan 9 164 1.5× 34 0.4× 153 1.9× 57 0.9× 14 0.2× 35 409
Jaehwa Choi United States 10 114 1.0× 40 0.4× 38 0.5× 28 0.4× 32 0.6× 14 392
Giulia Ghibellini United States 12 71 0.7× 273 3.1× 112 1.4× 25 0.4× 8 0.1× 17 632
Kirsti Berg Norway 11 59 0.5× 22 0.2× 43 0.5× 108 1.6× 8 0.1× 14 375

Countries citing papers authored by M. Evans

Since Specialization
Citations

This map shows the geographic impact of M. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Evans more than expected).

Fields of papers citing papers by M. Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Evans. The network helps show where M. Evans may publish in the future.

Co-authorship network of co-authors of M. Evans

This figure shows the co-authorship network connecting the top 25 collaborators of M. Evans. A scholar is included among the top collaborators of M. Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Evans. M. Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Evans, M., Jennifer R. Ribeiro, Todd Maney, et al.. (2026). An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins. JAMA Network Open. 9(3). e260908–e260908.
2.
Hellmann, K., Jennifer L. Gilbert, M. Evans, Paul G. Cassell, & Roy Taylor. (1987). Effect of razoxane on metastases from colorectal cancer. Clinical & Experimental Metastasis. 5(1). 3–8. 10 indexed citations
3.
Gilbert, J M, K. Hellmann, M. Evans, et al.. (1986). Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: Five-year follow-up. British journal of surgery. 73(6). 446–450. 20 indexed citations
4.
Evans, M.. (1984). Use of Nifedipine as an Adjunct to Current Antihypertensive Therapy. Archives of Internal Medicine. 144(5). 985–985. 23 indexed citations
5.
Gilbert, J M, et al.. (1984). Sites of recurrent tumour after ‘curative’ colorectal surgery: Implications for adjuvant therapy. British journal of surgery. 71(3). 203–205. 80 indexed citations
6.
Lombard, C, et al.. (1984). Blood pressure, electrocardiogram and echocardiogram measurements in the growing pony foal. Equine Veterinary Journal. 16(4). 342–347. 62 indexed citations
7.
Gilbert, J M, K. Hellmann, M. Evans, et al.. (1982). Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer. Cancer Chemotherapy and Pharmacology. 8(3). 10 indexed citations
8.
Gilbert, J M, et al.. (1981). A Controlled Prospective Trial of Adjuvant Razoxane in Resectable Colorectal Cancer. Recent results in cancer research. 79. 48–58. 1 indexed citations
9.
Cummins, J.T., et al.. (1980). Identification of harman in the rat arcuate nucleus. Naunyn-Schmiedeberg s Archives of Pharmacology. 310(3). 227–230. 48 indexed citations
10.
Weber, William P., et al.. (1980). Mass spectrometry of aryl substituted di‐ and trisiloxanes. Organic Mass Spectrometry. 15(6). 304–311. 11 indexed citations
11.
Bidder, T. George, et al.. (1979). Harman in human platelets. Life Sciences. 25(2). 157–164. 52 indexed citations
12.
Bidder, T. George, et al.. (1979). Combined gas chromatography and mass spectrometry of aromatic β-carbolines. Journal of Chromatography A. 174(1). 159–164. 12 indexed citations
13.
Howitt, G., et al.. (1968). The effect of the dextro isomer of propranolol on sinus rate and cardiac arrhythmias. American Heart Journal. 76(6). 736–745. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026